|
TSPAN5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.62458935193399E-12 |
| Normal-vs-Stage3 |
1.62470037423645E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.248600E-01 |
| Stage1-vs-Stage3 |
6.468000E-01 |
| Stage1-vs-Stage4 |
3.863500E-02 |
| Stage2-vs-Stage3 |
5.185600E-01 |
| Stage2-vs-Stage4 |
3.812400E-01 |
| Stage3-vs-Stage4 |
1.636040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
3.957000E-03 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
4.077000E-01 |
| Caucasian-vs-Asian |
2.022200E-01 |
| AfricanAmerican-vs-Asian |
2.438600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.356390E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
2.83649999999191E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.851200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.695800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.172400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.458400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.883200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.700000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.255800E-01 |
| Classical-VS-Follicular |
3.896600E-01 |
| Classical-VS-Other |
4.774600E-01 |
| Classical-VS-Normal |
3.33066907387547E-16 |
| Tall-VS-Follicular |
2.288800E-01 |
| Tall-VS-Other |
6.646200E-01 |
| Tall-VS-Normal |
1.62547753035369E-12 |
| Follicular-VS-Other |
2.077400E-01 |
| Follicular-VS-Normal |
7.55973061927762E-12 |
| Other-VS-Normal |
1.14690000052597E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.476600E-03 |
|
|
